Aspirin alleviates endothelial gap junction dysfunction through inhibition of NLRP3 inflammasome activation in LPS-induced vascular injury
2019 · Acta Pharmaceutica Sinica B · 100 citations
https://doi.org/10.1016/j.apsb.2019.02.008
L
Lingjun Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
148
Papers
2.0K
Citations
23
h-index
52
i10-index
Lingjun Wang is an academic researcher from Guangzhou University of Chinese Medicine. The author has contributed to research in topics: Cardiac Fibrosis and Remodeling & Autophagy in Disease and Therapy & Advanced Glycation End Products research. The author has an h-index of 23, co-authored 126 publications.
ORCID: 0000-0001-6214-5182Papers by this author
worksG-MDSCs promote aging-related cardiac fibrosis by activating myofibroblasts and preventing senescence
2021 · Cell Death and Disease · 53 citations
https://doi.org/10.1038/s41419-021-03874-7
Nuanxinkang protects against ischemia/reperfusion-induced heart failure through regulating IKKβ/IκBα/NF-κB-mediated macrophage polarization
2022 · Phytomedicine · 52 citations
https://doi.org/10.1016/j.phymed.2022.154093
FIBP knockdown attenuates growth and enhances chemotherapy in colorectal cancer via regulating GSK3β-related pathways
2018 · Oncogenesis · 37 citations
https://doi.org/10.1038/s41389-018-0088-9
Transplantation of Isl1+ cardiac progenitor cells in small intestinal submucosa improves infarcted heart function
2017 · Stem Cell Research & Therapy · 36 citations
https://doi.org/10.1186/s13287-017-0675-2
Plantamajoside attenuates cardiac fibrosis via inhibiting <scp>AGEs activated‐RAGE</scp>/autophagy/<scp>EndMT</scp> pathway
2022 · Phytotherapy Research · 21 citations
https://doi.org/10.1002/ptr.7663
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat